CLINICAL_TRIALS
trial_result
· 2021-09-20
Clinical Trial Update: A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Renal Cell Carcinoma [Phase 2]
Summary
Phase 2 study of cabozantinib in Japanese patients with advanced renal cell carcinoma has completed; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Advanced Renal Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2021-09-20